Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT03682536
Brief Title: Efficacy and Safety Study of Luspatercept (ACE-536) Versus Epoetin Alfa for the Treatment of Anemia Due to IPSS-R Very Low, Low or Intermediate Risk Myelodysplastic Syndromes (MDS) in ESA Naïve Subjects Who Require Red Blood Cell Transfusions (COMMANDS)

First Submitted : September 7, 2018
First Submitted that Met QC Criteria : September 20, 2018
First Posted : September 24, 2018

Last Update Submitted that Met QC Criteria : October 6, 2021
Last Update Posted : October 7, 2021